AI
Monday, December 09, 2024 10:55:51 AM
If you have time, do a little forensic data analysis of the following trial. Maybe you will load more.
Why did Merck reactivate the old trial and enroll another 25 rGBM patients around the same time the combo trial was undergoing?
https://clinicaltrials.gov/study/NCT02852655?tab=history&a=14&b=15&compareMode=sideBySide#version-content-panel
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264695
https://cdn.clinicaltrials.gov/large-docs/55/NCT02852655/Prot_SAP_000.pdf
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121810
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
https://pubmed.ncbi.nlm.nih.gov/30742122/
Recent NWBO News
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
